Switch theme
Sign up to access all valuation multiples
Jamieson Wellness Inc is engaged in the manufacturing, development, distributing, and marketing of branded natural health products, including vitamins, minerals, and supplements. The company operates in two segments: The Jamieson brands and The Strategic Partners. The majority of its revenue comes from the Jamieson brand segment. Some of its brands are Jamieson, Youtheory, Progressive, Precision, Smart Solutions, and Iron Vegan. Geographically, the majority of its revenue is derived from the domestic market.
2014
1.3K+
LTM Revenue $556M
LTM EBITDA $107M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Jamieson Wellness has a last 12-month revenue (LTM) of $556M and a last 12-month EBITDA of $107M.
In the most recent fiscal year, Jamieson Wellness achieved revenue of $530M and an EBITDA of $82.7M.
Jamieson Wellness expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Jamieson Wellness valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $556M | XXX | $530M | XXX | XXX | XXX |
| Gross Profit | $213M | XXX | $199M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $107M | XXX | $82.7M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 16% | XXX | XXX | XXX |
| EBIT | $91.0M | XXX | $67.7M | XXX | XXX | XXX |
| EBIT Margin | 16% | XXX | 13% | XXX | XXX | XXX |
| Net Profit | $45.7M | XXX | $37.5M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $190M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Jamieson Wellness's stock price is CAD 36 (or $26).
Jamieson Wellness has current market cap of CAD 1.5B (or $1.1B), and EV of CAD 1.7B (or $1.3B).
See Jamieson Wellness trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.1B | XXX | XXX | XXX | XXX | $1.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Jamieson Wellness has market cap of $1.1B and EV of $1.3B.
Jamieson Wellness's trades at 2.4x EV/Revenue multiple, and 15.2x EV/EBITDA.
Equity research analysts estimate Jamieson Wellness's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Jamieson Wellness has a P/E ratio of 23.5x.
See valuation multiples for Jamieson Wellness and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 2.3x | XXX | 2.4x | XXX | XXX | XXX |
| EV/EBITDA | 11.7x | XXX | 15.2x | XXX | XXX | XXX |
| EV/EBIT | 13.8x | XXX | 18.6x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 23.5x | XXX | 28.7x | XXX | XXX | XXX |
| EV/FCF | 28.8x | XXX | 33.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialJamieson Wellness's last 12 month revenue growth is 11%
Jamieson Wellness's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Jamieson Wellness's rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Jamieson Wellness's rule of X is 46% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Jamieson Wellness and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | 21% | XXX | XXX | XXX |
| Rule of 40 | 27% | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 46% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 25% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| SynBiotic | XXX | XXX | XXX | XXX | XXX | XXX |
| Mega Lifesciences | XXX | XXX | XXX | XXX | XXX | XXX |
| Procter & Gamble Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Abbott India | XXX | XXX | XXX | XXX | XXX | XXX |
| Sanofi India | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Jamieson Wellness acquired XXX companies to date.
Last acquisition by Jamieson Wellness was XXXXXXXX, XXXXX XXXXX XXXXXX . Jamieson Wellness acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Jamieson Wellness founded? | Jamieson Wellness was founded in 2014. |
| Where is Jamieson Wellness headquartered? | Jamieson Wellness is headquartered in Canada. |
| How many employees does Jamieson Wellness have? | As of today, Jamieson Wellness has 1.3K+ employees. |
| Who is the CEO of Jamieson Wellness? | Jamieson Wellness's CEO is Mr. Michael Pilato. |
| Is Jamieson Wellness publicy listed? | Yes, Jamieson Wellness is a public company listed on TSE. |
| What is the stock symbol of Jamieson Wellness? | Jamieson Wellness trades under JWEL ticker. |
| When did Jamieson Wellness go public? | Jamieson Wellness went public in 2017. |
| Who are competitors of Jamieson Wellness? | Similar companies to Jamieson Wellness include e.g. SynBiotic, Mega Lifesciences, Procter & Gamble Health, Abbott India. |
| What is the current market cap of Jamieson Wellness? | Jamieson Wellness's current market cap is $1.1B |
| What is the current revenue of Jamieson Wellness? | Jamieson Wellness's last 12 months revenue is $556M. |
| What is the current revenue growth of Jamieson Wellness? | Jamieson Wellness revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Jamieson Wellness? | Current revenue multiple of Jamieson Wellness is 2.3x. |
| Is Jamieson Wellness profitable? | Yes, Jamieson Wellness is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Jamieson Wellness? | Jamieson Wellness's last 12 months EBITDA is $107M. |
| What is Jamieson Wellness's EBITDA margin? | Jamieson Wellness's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Jamieson Wellness? | Current EBITDA multiple of Jamieson Wellness is 11.7x. |
| What is the current FCF of Jamieson Wellness? | Jamieson Wellness's last 12 months FCF is $43.8M. |
| What is Jamieson Wellness's FCF margin? | Jamieson Wellness's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of Jamieson Wellness? | Current FCF multiple of Jamieson Wellness is 28.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
